JMP Securities Downgrades Haemonetics (HAE) to Market Perform
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $75.07 +0.29%
Rating Summary:
10 Buy, 10 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 0
Rating Summary:
10 Buy, 10 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 0
Join SI Premium – FREE
JMP Securities downgraded Haemonetics (NYSE: HAE) from Market Outperform to Market Perform and removed its price target (priro $45.00).
For an analyst ratings summary and ratings history on Haemonetics click here. For more ratings news on Haemonetics click here.
Shares of Haemonetics closed at $37.19 yesterday.
For an analyst ratings summary and ratings history on Haemonetics click here. For more ratings news on Haemonetics click here.
Shares of Haemonetics closed at $37.19 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- HSBC Downgrades HK Electric (2638:HK) (HKCVF) to Hold
- ICICI Securities Downgrades Tech Mahindra Ltd. (TECHM:IN) to Reduce (4)
- ICICI Securities Downgrades Hexaware Technologies (HEXW:IN) to Add (2)
Create E-mail Alert Related Categories
DowngradesRelated Entities
JMP SecuritiesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
